These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 32418059)

  • 21. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis.
    Guo F; Nimmanapalli R; Paranawithana S; Wittman S; Griffin D; Bali P; O'Bryan E; Fumero C; Wang HG; Bhalla K
    Blood; 2002 May; 99(9):3419-26. PubMed ID: 11964312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
    Akara-Amornthum P; Lomphithak T; Choksi S; Tohtong R; Jitkaew S
    PLoS One; 2020; 15(1):e0227454. PubMed ID: 31914150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis.
    Cristofanon S; Abhari BA; Krueger M; Tchoghandjian A; Momma S; Calaminus C; Vucic D; Pichler BJ; Fulda S
    Cell Death Dis; 2015 Apr; 6(4):e1724. PubMed ID: 25880091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.
    Jaco I; Annibaldi A; Lalaoui N; Wilson R; Tenev T; Laurien L; Kim C; Jamal K; Wicky John S; Liccardi G; Chau D; Murphy JM; Brumatti G; Feltham R; Pasparakis M; Silke J; Meier P
    Mol Cell; 2017 Jun; 66(5):698-710.e5. PubMed ID: 28506461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
    Ng CP; Bonavida B
    Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
    Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U
    Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.
    Fandy TE; Shankar S; Srivastava RK
    Mol Cancer; 2008 Jun; 7():60. PubMed ID: 18590557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.
    Moriwaki K; Bertin J; Gough PJ; Orlowski GM; Chan FK
    Cell Death Dis; 2015 Feb; 6(2):e1636. PubMed ID: 25675296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
    Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
    Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of RIPK1 and FADD are associated with chemosensitivity and survival in head and heck squamous cell carcinoma via tanshinone IIA-mediated modulation of the RIPK1-FADD-Caspase 8 complex.
    Shen B; Han W; Tan X; Gu KJ; Naseem DF; Zheng G; Li G; Lou J; Chen C
    Mol Carcinog; 2024 Jul; 63(7):1406-1416. PubMed ID: 38695620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirement of nuclear factor κB for Smac mimetic-mediated sensitization of pancreatic carcinoma cells for gemcitabine-induced apoptosis.
    Stadel D; Cristofanon S; Abhari BA; Deshayes K; Zobel K; Vucic D; Debatin KM; Fulda S
    Neoplasia; 2011 Dec; 13(12):1162-70. PubMed ID: 22241962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer.
    Hashim YM; Vangveravong S; Sankpal NV; Binder PS; Liu J; Goedegebuure SP; Mach RH; Spitzer D; Hawkins WG
    J Exp Clin Cancer Res; 2017 Jan; 36(1):14. PubMed ID: 28095907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma.
    Crawford N; Stasik I; Holohan C; Majkut J; McGrath M; Johnston PG; Chessari G; Ward GA; Waugh DJ; Fennell DA; Longley DB
    Cell Death Dis; 2013 Jul; 4(7):e733. PubMed ID: 23868066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
    Bockbrader KM; Tan M; Sun Y
    Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
    Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
    Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.
    Kamata E; Kawamoto T; Ueha T; Hara H; Fukase N; Minoda M; Morishita M; Takemori T; Fujiwara S; Nishida K; Kuroda R; Kurosaka M; Akisue T
    Anticancer Res; 2017 Nov; 37(11):6097-6106. PubMed ID: 29061790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosis.
    Reiter M; Eckhardt I; Haferkamp A; Fulda S
    Cancer Lett; 2016 May; 375(1):1-8. PubMed ID: 26912071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation.
    Henry CM; Martin SJ
    Mol Cell; 2017 Feb; 65(4):715-729.e5. PubMed ID: 28212752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
    Wu P; Shi KJ; An JJ; Ci YL; Li F; Hui KY; Yang Y; Xu CM
    Cell Death Dis; 2014 Feb; 5(2):e1085. PubMed ID: 24577083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of FADD and Caspases Affects the Response of T-Cell Leukemia Jurkat Cells to Anti-Cancer Drugs.
    Mrkvová Z; Portešová M; Slaninová I
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.